| 1. |
I.Amirzada,J.Sharif,Khan Q Potential drug-drug interactions in patients presenting with osteoarthritis to community orthopaedic clinics of Abbottabad, Khyber Pakhtunkhwa: a cross-sectional study, Annales Pharmaceutiques Françaises, 2023 |
| 2. |
M. Ashfaq,Yasser MSA Alkahraman,Mobasher,J.Sharif,Khan Q Long-Term Proton Pump Inhibitor Therapy and its Effect on Endocrine Hormones in Selected Patient Population, Hormone and Metabolic Research, 2023 |
| 3. |
J.Sharif,Shujaat A.K, SA Khan,Mobasher,M. Ashfaq,Khan Q Exploring the factors and barriers of healthcare professionals in tertiary care hospitals toward pharmacovigilance: a multicenter study from Khyber Pakhtunkhwa, Pakistan, Current Medical Research and Opinion , 2022 |
| 4. |
Khan Q Prevalence, predictors and outcomes of potential drug-drug interactions in left ventricular failure: considerable factors for quality use of medicines, Brazilian journal of pharmaceutical sciences, 2020 |
| 5. |
Khan Q Prevalence of QTc interval prolongation and its associated risk factors among psychiatric patients: a prospective observational study., BMC psychiatry, 2020 |
| 6. |
Zahid Ali,Khan Q,S Noor Prevalence of QTc interval prolongation and its associated risk factors among psychiatric patients: a prospective observational study, BMC Psychiatry, 2020 |
| 7. |
Inam ul Haq,Khan Q,S Noor Prevalence, predictors and outcomes of potential drug-drug interactions in left ventricular failure: considerable factors for quality use of medicines, Brazilian Journal of
Pharmaceutical Sciences, 2020 |
| 8. |
Khan Q Prevalence, predictors and outcomes of potential drug-drug interactions in patients with coronary artery disease: a cross sectional study., Latin american journal of pharmacy, 2019 |
| 9. |
Inam Ul Haq,Khan Q,S Noor Prevalence, predictors and outcomes of potential drug-drug interactions in patients with coronary artery disease: a cross sectional study, Latin American Journal of Pharmacy, 2019 |
| 10. |
Khan Q Potential drug-drug interactions in outpatient department of a tertiary care hospital in Pakistan: a cross-sectional study., BMC health services research, 2018 |
| 11. |
Muhammad Ismail Tajik,S Noor,Khan Q Potential drug-drug interactions in outpatient department of a tertiary care hospital in Pakistan: a cross-sectional study, BMC Health Services Research, 2018 |
| 12. |
Khan Q Moxifloxacin-induced QT interval prolongation and torsades de pointes: a narrative review., Expert opinion on drug safety, 2018 |
| 13. |
Khan Q High prevalence of the risk factors for QT interval prolongation and associated drug-drug interactions in coronary care units., Postgraduate medicine, 2018 |
| 14. |
Khan Q Prevalence of the risk factors for QT prolongation and associated drug-drug interactions in a cohort of medical inpatients., Journal of the Formosan Medical Association, 2018 |
| 15. |
Khan Q Frequency, characteristics and risk factors of QT interval prolonging drugs and drug-drug interactions in cancer patients: a multicenter study., BMC pharmacology & toxicology, 2017 |
| 16. |
Khan Q Prevalence of QT interval prolonging drug-drug interactions (QT-DDIs) in psychiatry wards of tertiary care hospitals in Pakistan: a multicenter cross-sectional study., International journal of clinical pharmacy, 2017 |
| 17. |
Khan Q QT interval prolongation in hospitalized patients on cardiology wards: a prospective observational study, European journal of clinical pharmacology, 2017 |
| 18. |
Mohammad Ismail Tajik,S Noor,Khan Q Potential drug-drug interactions in pediatric patients admitted to intensive care unit of Khyber Teaching Hospital, Peshawar, Pakistan: A cross-sectional study, Journal of Critical Care, 2017 |
| 19. |
Khan Q,S Noor QT interval prolongation in hospitalized patients on cardiology wards: a prospective observational study, European Journal of Clinical Pharmacology, 2017 |
| 20. |
Khan Q Potential drug-drug interactions in pediatric patients admitted to intensive care unit of Khyber Teaching Hospital, Peshawar, Pakistan: A cross-sectional study., Journal of critical care, 2017 |
